标准化Krishna Vajra Abhraka bhasma的毒性概况是由生物 mica制成的生物
Vijaya Anil Pandit1, Sharwan Kumar Singhal2, Gourav Bharat Deshmane3
1Bharati Vidyapeeth (DU) Medical College, Pune, India.
Journal of Ayurveda and integrative medicine
|December 1, 2024
概括
克里希纳·瓦贾拉·阿布拉卡·巴斯马 (KVB) 在急性毒性中是安全的,但在亚急性研究中可以在较高剂量时引起可逆性肝损伤. 谨慎的剂量和监测对于阿育吠陀实践至关重要.
科学领域:
- 艾尔韦达医学是一种医药.
- 药理学 药理学是指药理学的学科.
- 毒理学 毒理学 毒理学
背景情况:
- 巴斯马斯,草药矿物制剂,与潜在的不良影响有关.
- 评估Krishna Vajra Abhraka Bhasma (KVB) 的安全性对于临床使用至关重要.
研究的目的:
- 评估克里希纳·瓦贾拉·阿布拉卡·巴斯马 (KVB) 的安全情况.
- 通过动物研究来确定KVB的急性和亚急性毒性.
主要方法:
- 急性毒性测试涉及雌性大鼠一次性口服KVB剂量 (2000毫克/公斤).
- 在亚急性毒性研究中,在28天内向大鼠服用不同的口服剂量KVB.
- 进行了标准的毒理学评估,包括血液学,功能和组织病理学.
主要成果:
- 在急性毒性研究中没有观察到死亡率或不良反应.
- 亚急性研究表明,在低剂量下,体重,器官重量,血液学或功能没有显著变化.
- 在中高剂量KVB时观察到肝毒性,可逆且剂量依赖.
结论:
- 根据急性毒性,KVB被归类为安全 (GHS V类).
- 低剂量的KVB似乎无毒,但高剂量可以诱导可逆性肝毒性.
- 这些发现强调了在涉及KVB的阿育吠陀治疗中需要谨慎的剂量和患者监测.
相关概念视频
Toxic Reactions: Overview
3.9K
When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
3.9K
Drug Toxicity: Overview
216
Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...
216
Drug Toxicity: Risk factors
206
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
206
Drug Toxicity: Dose-Dependent Reactions
200
Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
200
Bioactivation and Tissue Toxicity
116
Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...
116
Toxicity Testing in Animals
150
Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
150


